Recommendations for using smallpox vaccine in a pre-event vaccination program, Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC), pp.1-16, 2003. ,
Use of Adenovirus in Vaccines for HIV, Handb Exp Pharmacol, pp.275-293, 2009. ,
DOI : 10.1007/978-3-540-71029-5_13
Vaccines in Healthy Adults, AIDS Research and Human Retroviruses, vol.25, issue.1, pp.103-114, 2009. ,
DOI : 10.1089/aid.2008.0212
Why vaccines are not the answer ??? The failure of V520 and the importance of cell-mediated immunity in the fight against HIV, Medical Hypotheses, vol.71, issue.6, pp.909-913, 2008. ,
DOI : 10.1016/j.mehy.2008.07.027
CD8+ T-cell memory to viruses, Current Opinion in Immunology, vol.6, issue.4, pp.545-552, 1994. ,
DOI : 10.1016/0952-7915(94)90139-2
VACCINES: EFFECTOR AND MEMORY T-CELL DIFFERENTIATION: IMPLICATIONS FOR VACCINE DEVELOPMENT, Nature Reviews Immunology, vol.166, issue.4, pp.251-262, 2002. ,
DOI : 10.1046/j.1365-2249.2001.01600.x
T cells versus HIV-1: fighting exhaustion as well as escape, Nature Immunology, vol.4, issue.1, pp.12-13, 2003. ,
DOI : 10.1038/ni0103-12
Immunological determinants of the outcomes from primary hepatitis C infection, Cellular and Molecular Life Sciences, vol.66, issue.5, pp.733-756, 2009. ,
DOI : 10.1007/s00018-008-8270-4
Prospects for an influenza vaccine that induces crossprotective cytotoxic T lymphocytes, Immunol Cell Biol, 2009. ,
T-cell quality in memory and protection: implications for vaccine design, Nature Reviews Immunology, vol.27, issue.4, pp.247-258, 2008. ,
DOI : 10.1038/nri2274
Human Effector and Memory CD8+ T Cell Responses to??Smallpox and Yellow Fever Vaccines, Immunity, vol.28, issue.5, pp.710-722, 2008. ,
DOI : 10.1016/j.immuni.2008.02.020
Polyclonal CTL Responses Observed in Melanoma Patients Vaccinated with Dendritic Cells Pulsed with a MAGE-3.A1 Peptide, The Journal of Immunology, vol.171, issue.9, pp.4893-4897, 2003. ,
DOI : 10.4049/jimmunol.171.9.4893
Functional profile of human influenza virus-specific cytotoxic T lymphocyte activity is influenced by interleukin-2 concentration and epitope specificity, Clinical and Experimental Immunology, vol.172, issue.1, pp.45-52, 2005. ,
DOI : 10.1006/cimm.1996.0245
Recognition of Homo- and Heterosubtypic Variants of Influenza A Viruses by Human CD8+ T Lymphocytes, The Journal of Immunology, vol.172, issue.4, pp.2453-2460, 2004. ,
DOI : 10.4049/jimmunol.172.4.2453
High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens, The Journal of Experimental Medicine, vol.58, issue.2, pp.241-248, 2005. ,
DOI : 10.1126/science.1076514
Cytotoxic T-cell memory without antigen, Nature, vol.369, issue.6482, pp.648-652, 1994. ,
DOI : 10.1038/369648a0
Duration of antiviral immunity after smallpox vaccination, Nature Medicine, vol.9, issue.9, 2003. ,
DOI : 10.1038/nm917
Distinct Time Effects of Vaccination on Long-Term Proliferative and IFN-?????producing T Cell Memory to Smallpox in Humans, The Journal of Experimental Medicine, vol.512, issue.11, pp.1585-1593, 2004. ,
DOI : 10.1126/science.277.5322.112
Human cytotoxic Tcell memory: long-lived responses to vaccinia virus, J Virol, vol.70, pp.2627-2631, 1996. ,
Dendritic cells as therapeutic vaccines against cancer, Nature Reviews Immunology, vol.10, issue.4, pp.296-306, 2005. ,
DOI : 10.1007/s00262-003-0429-0
Dendritic cells and the control of immunity, Nature, vol.392, issue.6673, pp.245-252, 1998. ,
DOI : 10.1038/32588
Immune surveillance in the skin: mechanisms and clinical consequences, Nature Reviews Immunology, vol.101, issue.3, pp.211-222, 2004. ,
DOI : 10.1038/nri1310
Functional Specializations of Human Epidermal Langerhans Cells and CD14+ Dermal Dendritic Cells, Immunity, vol.29, issue.3, pp.497-510, 2008. ,
DOI : 10.1016/j.immuni.2008.07.013
Particle-based vaccines for transcutaneous vaccination, Comparative Immunology, Microbiology and Infectious Diseases, vol.31, issue.2-3, pp.293-315, 2008. ,
DOI : 10.1016/j.cimid.2007.07.015
Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells, Journal of Clinical Investigation, vol.113, issue.7, pp.998-1007, 2004. ,
DOI : 10.1172/JCI20261
STRATEGIES FOR DESIGNING AND OPTIMIZING NEW GENERATION VACCINES, Nature Reviews Immunology, vol.163, issue.3, pp.209-219, 2001. ,
DOI : 10.1084/jem.193.2.233
Dendritic Cells Rapidly Recruited into Epithelial Tissues via CCR6/CCL20 Are Responsible for CD8+ T Cell Crosspriming In Vivo, Immunity, vol.24, issue.2, pp.191-201, 2006. ,
DOI : 10.1016/j.immuni.2006.01.005
URL : https://hal.archives-ouvertes.fr/inserm-00000041
The skin immune system: progress in cutaneous biology, Immunology Today, vol.14, issue.2, pp.75-78, 1993. ,
DOI : 10.1016/0167-5699(93)90062-P
Skin immunization made possible by cholera toxin, Nature, vol.391, issue.6670, p.851, 1998. ,
DOI : 10.1038/36014
Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge, J Immunol, vol.161, pp.3211-3214, 1998. ,
Transcutaneous Immunization, Nat Med, vol.6, pp.1403-1406, 2000. ,
DOI : 10.1385/1-59259-083-7:315
Transcutaneous immunization: T cell responses and boosting of existing immunity, Vaccine, vol.19, issue.17-19, pp.2701-2707, 2001. ,
DOI : 10.1016/S0264-410X(00)00506-5
Needle-Free Skin Patch Vaccination Method for Anthrax, Infection and Immunity, vol.72, issue.2, pp.1181-1183, 2004. ,
DOI : 10.1128/IAI.72.2.1181-1183.2004
Transcutaneous immunization with heat-labile enterotoxin: development of a needle-free vaccine patch, Expert Review of Vaccines, vol.6, issue.5, pp.809-819, 2007. ,
DOI : 10.1586/14760584.6.5.809
Controlled, single-step, stratum corneum disruption as a pretreatment for immunization via a patch, Vaccine, vol.26, issue.22, pp.2782-2787, 2008. ,
DOI : 10.1016/j.vaccine.2008.02.070
40nm, but not 750 or 1,500nm, Nanoparticles Enter Epidermal CD1a+ Cells after Transcutaneous Application on Human Skin, Journal of Investigative Dermatology, vol.126, issue.6, pp.1316-1322, 2006. ,
DOI : 10.1038/sj.jid.5700226
Transcutaneous Anti-Influenza Vaccination Promotes Both CD4 and CD8 T Cell Immune Responses in Humans, The Journal of Immunology, vol.180, issue.3, pp.1482-1489, 2008. ,
DOI : 10.4049/jimmunol.180.3.1482
Follicular Targeting???A Promising Tool in Selective Dermatotherapy, Journal of Investigative Dermatology Symposium Proceedings, vol.10, issue.3, pp.252-255, 2005. ,
DOI : 10.1111/j.1087-0024.2005.10124.x
Influenza and the challenge for immunology, Nature Immunology, vol.165, issue.5, pp.449-455, 2006. ,
DOI : 10.1038/ni1343
Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population, Proceedings of the National Academy of Sciences, vol.106, issue.48, pp.20365-20370, 2009. ,
DOI : 10.1073/pnas.0911580106
Immunity to Respiratory Viruses, Annual Review of Immunology, vol.27, issue.1, pp.61-82, 2009. ,
DOI : 10.1146/annurev.immunol.021908.132625
Naive, effector, and memory CD8 T cells in protection against pulmonary influenza virus infection: homing properties rather than initial frequencies are crucial, J Immunol, vol.163, pp.5535-5543, 1999. ,
The outcome of T-cell costimulation through intercellular adhesion molecule-1 differs from costimulation through leucocyte function-associated antigen-1, Immunology, vol.161, issue.2, pp.152-157, 2003. ,
DOI : 10.1126/science.1064571
Toward an AIDS Vaccine, Science, vol.320, issue.5877, pp.760-764, 2008. ,
DOI : 10.1126/science.1152622
Impact of MHC class I diversity on immune control of immunodeficiency virus replication, Nature Reviews Immunology, vol.80, issue.8, pp.619-630, 2008. ,
DOI : 10.1038/nri2357
Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans, Nature Medicine, vol.21, issue.6, pp.617-621, 2008. ,
DOI : 10.1038/nm.f.1759
Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge, Nature Medicine, vol.72, issue.3, pp.293-299, 2009. ,
DOI : 10.1097/00002030-199801000-00001
Nanoparticle-Based Targeting of Vaccine Compounds to Skin Antigen-Presenting Cells By Hair Follicles and their Transport in Mice, Journal of Investigative Dermatology, vol.129, issue.5, 2008. ,
DOI : 10.1038/jid.2008.356
Distinct dendritic cell subsets differentially regulate the class of immune response in vivo, Proceedings of the National Academy of Sciences, vol.96, issue.3, pp.1036-1041, 1999. ,
DOI : 10.1073/pnas.96.3.1036
Differential Antigen Processing by Dendritic Cell Subsets in Vivo, Science, vol.315, issue.5808, pp.107-111, 2007. ,
DOI : 10.1126/science.1136080
Migratory Langerhans Cells in Mouse Lymph Nodes in Steady State and Inflammation, Journal of Investigative Dermatology, vol.125, issue.1, pp.116-125, 2005. ,
DOI : 10.1111/j.0022-202X.2005.23757.x
Langerhans cells cross-present antigen derived from skin, Proceedings of the National Academy of Sciences, vol.103, issue.20, pp.7783-7788, 2006. ,
DOI : 10.1073/pnas.0509307103
Langerhans cells ??? revisiting the paradigm using genetically engineered mice, Trends in Immunology, vol.27, issue.3, pp.132-139, 2006. ,
DOI : 10.1016/j.it.2006.01.003
URL : https://hal.archives-ouvertes.fr/hal-00080584
IFN-?? enables cross-presentation of exogenous protein antigen in human Langerhans cells by potentiating maturation, Proceedings of the National Academy of Sciences, vol.101, issue.40, pp.14467-14472, 2004. ,
DOI : 10.1073/pnas.0405947101
Mature Human Langerhans Cells Derived from CD34+ Hematopoietic Progenitors Stimulate Greater Cytolytic T Lymphocyte Activity in the Absence of Bioactive IL-12p70, by Either Single Peptide Presentation or Cross-Priming, Than Do Dermal-Interstitial or Monocyte-Derived Dendritic Cells, The Journal of Immunology, vol.173, issue.4, pp.2780-2791, 2004. ,
DOI : 10.4049/jimmunol.173.4.2780
Mucosal AIDS vaccines: current status and future directions, Expert Review of Vaccines, vol.3, issue.sup1, pp.65-73, 2004. ,
DOI : 10.1586/14760584.3.4.S65
Variations of Hair Follicle Size and Distribution in Different Body Sites, Journal of Investigative Dermatology, vol.122, issue.1, pp.14-19, 2004. ,
DOI : 10.1046/j.0022-202X.2003.22110.x
Ethnic Variation in Vellus Hair Follicle Size and Distribution, Skin Pharmacology and Physiology, vol.19, issue.3, pp.159-167, 2006. ,
DOI : 10.1159/000093050
Safety and efficacy of transcutaneous vaccination using a patch with the live-attenuated measles vaccine in humans, Vaccine, vol.25, issue.39-40, pp.6891-6899, 2007. ,
DOI : 10.1016/j.vaccine.2007.07.014
Induction of Therapeutically Relevant Cytotoxic T Lymphocytes in Humans by Percutaneous Peptide Immunization, Cancer Research, vol.66, issue.20, pp.10136-10144, 2006. ,
DOI : 10.1158/0008-5472.CAN-06-1029
Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections, Immunological Reviews, vol.155, issue.1, pp.105-117, 1997. ,
DOI : 10.1016/0952-7915(93)90026-O
Virus-specific CD8+ T-cell memory determined by
clonal burst size, Nature, vol.369, issue.6482, pp.652-654, 1994. ,
DOI : 10.1038/369652a0
Memory T Cells by Viral Variants, The Journal of Experimental Medicine, vol.152, issue.9, pp.1319-1328, 1999. ,
DOI : 10.1084/jem.188.9.1705
Protection against influenza virus challenge by topical application of influenza DNA vaccine, Vaccine, vol.19, issue.31, pp.4434-4444, 2001. ,
DOI : 10.1016/S0264-410X(01)00194-3
Resistance to and Recovery from Lethal Influenza Virus Infection in B Lymphocyte???deficient Mice, The Journal of Experimental Medicine, vol.155, issue.12, pp.2063-2068, 1997. ,
DOI : 10.1084/jem.183.5.2153
Mechanism of protective immunity against influenza virus infection in mice without antibodies, J Immunol, vol.160, pp.322-327, 1998. ,
Viral recognition by influenza A virus cross-reactive cytotoxic T (Tc) cells: The proportion of Tc cells that recognize nucleoprotein varies between individual mice, European Journal of Immunology, vol.35, issue.2, pp.193-198, 1986. ,
DOI : 10.1002/eji.1830160215
The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides, Cell, vol.44, issue.6, pp.959-968, 1986. ,
DOI : 10.1016/0092-8674(86)90019-X
Virus-Specific and Bystander CD8+ T-Cell Proliferation in the Acute and Persistent Phases of a Gammaherpesvirus Infection, Journal of Virology, vol.75, issue.9, pp.4435-4438, 2001. ,
DOI : 10.1128/JVI.75.9.4435-4438.2001
Diversity of Epitope and Cytokine Profiles for Primary and Secondary Influenza A Virus-Specific CD8+ T Cell Responses, The Journal of Immunology, vol.166, issue.7, pp.4627-4633, 2001. ,
DOI : 10.4049/jimmunol.166.7.4627
A Previously Unrecognized H-2Db-Restricted Peptide Prominent in the Primary Influenza A Virus-Specific CD8+ T-Cell Response Is Much Less Apparent following Secondary Challenge, Journal of Virology, vol.74, issue.8, pp.3486-3493, 2000. ,
DOI : 10.1128/JVI.74.8.3486-3493.2000
Definition of amino acid residues on the epitope responsible for recognition by influenza A virus H1- specific, H2-specific, and H1-and H2-cross-reactive murine cytotoxic Tlymphocyte clones, J Virol, vol.72, pp.9404-9406, 1998. ,
Cross-reactive protection against influenza A virus infections by an NS1-specific CTL clone, Virology, vol.178, issue.1, pp.174-179, 1990. ,
DOI : 10.1016/0042-6822(90)90391-4
Active immunization against virus infections due to antigenic drift by induction of crossreactive cytotoxic T lymphocytes, Journal of Experimental Medicine, vol.169, issue.4, pp.1361-1371, 1989. ,
DOI : 10.1084/jem.169.4.1361
Cytotoxic T Lymphocytes Recognize a Cross-Reactive Epitope on the Transmembrane Region of Influenza H1 and H2 Hemagglutinins, Viral Immunology, vol.2, issue.3, pp.163-173, 1989. ,
DOI : 10.1089/vim.1989.2.163
HA2 subunit of influenza A H1 and H2 subtype viruses induces a protective cross-reactive cytotoxic T lymphocyte response, J Immunol, vol.140, pp.1264-1268, 1988. ,
Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly, Experimental Gerontology, vol.37, issue.2-3, pp.427-439, 2002. ,
DOI : 10.1016/S0531-5565(01)00210-8
Immune response to influenza vaccination in a large healthy elderly population, Vaccine, vol.17, issue.1, pp.82-94, 1999. ,
DOI : 10.1016/S0264-410X(98)00117-0
Polyfunctional analysis of human t cell responses: importance in vaccine immunogenicity and natural infection, Springer Seminars in Immunopathology, vol.102, issue.12, pp.209-219, 2006. ,
DOI : 10.1007/s00281-006-0025-4
Functional signatures of protective antiviral T-cell immunity in human virus infections, Immunological Reviews, vol.17, issue.1, pp.236-254, 2006. ,
DOI : 10.1146/annurev.med.54.101601.152349
Immunization via hair follicles by topical application of naked DNA to normal skin, Nat Biotechnol, vol.17, pp.870-872, 1999. ,
Follicular Penetration and Targeting, Journal of Investigative Dermatology Symposium Proceedings, vol.10, issue.3, pp.301-303, 2005. ,
DOI : 10.1111/j.1087-0024.2005.10121.x
URL : http://doi.org/10.1111/j.1087-0024.2005.10121.x
Hair Follicles ??? A Long-Term Reservoir for Drug Delivery, Skin Pharmacology and Physiology, vol.19, issue.4, pp.232-236, 2006. ,
DOI : 10.1159/000093119
Transcutaneous immunization by merely prolonging the duration of antigen presence on the skin of mice induces a potent antigen-specific antibody response even in the absence of an adjuvant, Vaccine, vol.25, issue.52, pp.8762-8770, 2007. ,
DOI : 10.1016/j.vaccine.2007.10.031
Mass Vaccination: Solutions in the Skin, Curr Top Microbiol Immunol, vol.304, pp.247-268, 2006. ,
DOI : 10.1007/3-540-36583-4_14
Dose Sparing with Intradermal Injection of Influenza Vaccine, New England Journal of Medicine, vol.351, issue.22, pp.2295-2301, 2004. ,
DOI : 10.1056/NEJMoa043540
A Phase I, Randomized, Controlled Trial to Study the Reactogenicity and Immunogenicity of a Nasal, Inactivated Trivalent Influenza Virus Vaccine in Healthy Adults, Human Vaccines, vol.1, issue.1, pp.37-42, 2005. ,
DOI : 10.4161/hv.1.1.1553
Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses, Journal of Immunological Methods, vol.275, issue.1-2, pp.19-29, 2003. ,
DOI : 10.1016/S0022-1759(02)00541-0
Simultaneous Analysis of the Cyan, Green, and Yellow Fluorescent Proteins, Curr Protoc Cytom Chapter, vol.369, p.16, 2001. ,
DOI : 10.1002/0471142956.cy0116s16
The assessment of antigen-specific CD8+ T cells through the combination of MHC class I tetramer and intracellular staining, Journal of Immunological Methods, vol.268, issue.1, pp.9-19, 2002. ,
DOI : 10.1016/S0022-1759(02)00195-3
T Cells Produce Antiviral Cytokines but Are Impaired in Cytolytic Function, The Journal of Experimental Medicine, vol.139, issue.1, pp.63-75, 2000. ,
DOI : 10.1086/314868